WhichRecall
Class IIReported 2026-01-28

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Recalled by Zydus Pharmaceuticals (USA) Inc

Reason for Recall

Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules

Advertisement

Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.

Recall Number
D-0295-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-12-30
Reported
2026-01-28
Distribution
US Nationwide.
Code Info
Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement